Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma-Reference-Cited by-同舟云学术

Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma

Published:2006 Issue:7 Volume:106 Page:1431-1442
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Verma Shailendra,Quirt Ian,McCready David,Bak Kate,Charette Manya,Iscoe Neill,

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference53 articles.

1. National Cancer Institute of Canada. Canadian cancer statistics 2005. Toronto, Ontario: National Cancer Institute of Canada, 2005.

2. , . Immunological relationship between melanoma and host. In: , , editors. Cutaneous melanoma biology and management. Milan: Masson; 1990: 139–151.

3. , . Regressing melanoma and depigmentation. In: , , editors. Cutaneous melanoma biology and management. Milan: Masson; 1990: 159–166.

4. Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spin in Abstracts of Systematic Reviews and Meta-analyses of Melanoma Therapies: Cross-sectional Analysis;JMIR Dermatology;2022-02-24

2. Malignes Melanom und andere Hauttumoren;Allgemein- und Viszeralchirurgie I;2022

3. Adjuvant therapy of malignant melanoma: general and practical experience;Onkologie;2021-09-01

4. Adjuvant Therapy of High-Risk (Stages IIC–IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2021-02-18

5. Systemic adjuvant therapy for adult patients at high risk for recurrent melanoma: A systematic review;Cancer Treatment Reviews;2020-07